TA
LXRX icon

Teton Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Teton Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,286
Closed -$52K – 538
2014
Q3 		$52K Sell
5,286
-28,285
-84% -$302K ﹤0.01% 516
2014
Q2 		$378K Hold
33,571
– – 0.03% 442
2014
Q1 		$407K Hold
33,571
– – 0.03% 432
2013
Q4 		$423K Hold
33,571
– – 0.03% 418
2013
Q3 		$559K Buy
33,571
+714
+2% +$12K 0.04% 380
2013
Q2 		$499K Buy
+32,857
New +$499K 0.04% 371

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Teton Advisors's LXRX Position: Q4 2014 in Review

Teton Advisors sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2014, closing a stake of 5,286 shares — an estimated $52K sold.

Teton Advisors first reported a position in LXRX in Q2 2013 and held it in 6 quarters. The position peaked at $559K in Q3 2013. 123 funds tracked by Wall St. Rank hold LXRX as of Q4 2014.

  • Teton Advisors reported no remaining Lexicon Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Teton Advisors sold 5,286 Lexicon Pharmaceuticals shares in Q4 2014, an estimated $52K.
  • Teton Advisors first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Teton Advisors's Lexicon Pharmaceuticals position peaked at $559K in Q3 2013.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2014.

Based on Teton Advisors's 13F filing for Q4 2014, filed 5 Feb 2015.